סגלורומט 2.5/1000 מ"ג - Segluromet 2.5/1000 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×¡××××¨××× 7.5/1000 ×"× - Segluromet 7.5/1000 mg

×§×××¦× ×¤×¨××§××××××ª (ATC4)

A10BD
Combinations of oral blood glucose lowering drugs

××¨××× ×¤×¢×× (ATC5)

Ertugliflozin (L-PGA) 2.5 MG â A10BD23
Metformin hydrochloride 1000 MG â A10BD23

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:â¢ in patients not adequately controlled on their maximally tolerated dose of metformin aloneâ¢ in patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetes â¢ in patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

16/01/2019

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××
×¡×××¨×ª ××××× ×¡×××¨×ª ×¡×× 2 ××¢×× ×× ×¢× ×× ×××: ×. HbA1c ××¢×¨× 7% ×××¢××, ×¢× ××£ ×××¤×× ×§××× ×××××ª×. ×. eGFR ××¢×¨× 45 ×"×/××§×/1.73 ×"×¨ ×××¢××, ×× ××¢×¨× ×××× ×××ª×¨ ×××ª×× ××ª× ×× ××¨××©××. ×. ×××× × ×©× ××× ××××: 1. ×××× ××©×¨××¨ ××× 2. × ××ª×× ××¢×§×¤×× (CABG) 3. ××××ª ×× ×××¡××××ª. 4. ×× ×¡×¤××§× ×××××ª××ª ××××××¨×ª ×××× ××××, ×××ª×× ××ª× ×× ××¨××©××: ×. eGFR × ××× ×-90 ×"×/××§× ××××§×¨×××××××× ××¨×× (×××××¨×ª ××××¡ ×§×¨×××× ×× ××××××× ××¢× 300 ×"×/××¨×). ×. eGFR × ××× ×-90 ×"×/××§× ××××§×¨×××××××× ××¨×× (×××××¨×ª ××××¡ ×§×¨×××× ×× ××××××× ××¢× 30 ×"×/××¨×). ×. eGFR × ××× ×-60 ×"×/××§×.	01/03/2021	×× ×××§×¨×× ××××××	DAPAGLIFLOZIN, ERTUGLIFLOZIN (L-PGA), EMPAGLIFLOZIN	×¡×××¨×ª ×¡×× 2
×¡×××¨×ª ×¡×× 2 ×××××× ××¢×× ×× ×¢× ×× ×××: ×. HbA1c ××¢×¨× 7% ×××¢××, ×¢× ××£ ×××¤×× ×§××× ×××××ª×. ×. eGFR ××¢×¨× 45 ×"×/××§×/1.73 ×"×¨ ×××¢××, ×× ××¢×¨× ×××× ×××ª×¨ ×××ª×× ××ª× ×× ××¨××©××. ×. ×××× × ×©× ××× ××××: 1. ×××× ××©×¨××¨ ××× 2. × ××ª×× ××¢×§×¤×× (CABG) 3. ××××ª ×× ×××¡××××ª. 4. ×× ×¡×¤××§× ×××××ª××ª ××××××¨×ª ×××× ××××, ×××ª×× ××ª× ×× ××¨××©××: ×. eGFR × ××× ×-90 ×"×/××§× ××××§×¨×××××××× ××¨×× (×××××¨×ª ××××¡ ×§×¨×××× ×× ××××××× ××¢× 300 ×"×/××¨×). ×. eGFR × ××× ×-60 ×"×/××§×.	30/01/2020	×× ×××§×¨×× ××××××	DAPAGLIFLOZIN, ERTUGLIFLOZIN (L-PGA), EMPAGLIFLOZIN	×¡×××¨×ª ×¡×× 2
×¡×××¨×ª ×¡×× 2 ×××××× ××¢×× ×× ×¢× ×× ×××: ×. HbA1c ××¢×¨× 7% ×××¢××, ×¢× ××£ ×××¤×× ×§××× ×××××ª×. ×. eGFR ××¢×¨× 45 ×"×/××§×/1.73 ×"×¨ ×××¢××, ×× ××¢×¨× ×××× ×××ª×¨ ×××ª×× ××ª× ×× ××¨××©××. ×. ×××× × ×©× ××× ××××: 1. ×××× ××©×¨××¨ ××× 2. × ××ª×× ××¢×§×¤×× (CABG) 3. ××××ª ×× ×××¡××××ª.	12/01/2017	×× ×××§×¨×× ××××××	DAPAGLIFLOZIN, ERTUGLIFLOZIN (L-PGA), EMPAGLIFLOZIN	×¡×××¨×ª ×¡×× 2

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××¡×××¨×ª ××××× ×¡×××¨×ª ×¡×× 2 ××¢×× ×× ×¢× ×× ×××:

×. HbA1c ××¢×¨× 7% ×××¢××, ×¢× ××£ ×××¤×× ×§××× ×××××ª×.

×. eGFR ××¢×¨× 45 ×"×/××§×/1.73 ×"×¨ ×××¢××, ×× ××¢×¨× ×××× ×××ª×¨ ×××ª×× ××ª× ×× ××¨××©××.

2. × ××ª×× ××¢×§×¤×× (CABG)

3. ××××ª ×× ×××¡××××ª.

×. eGFR × ××× ×-90 ×"×/××§× ××××§×¨×××××××× ××¨×× (×××××¨×ª ××××¡ ×§×¨×××× ×× ××××××× ××¢× 300 ×"×/××¨×).

×. eGFR × ××× ×-90 ×"×/××§× ××××§×¨×××××××× ××¨×× (×××××¨×ª ××××¡ ×§×¨×××× ×× ××××××× ××¢× 30 ×"×/××¨×).

×. eGFR × ××× ×-60 ×"×/××§×.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 01.02.2022

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 01.02.2022 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leaflet â01.02.2022 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 01.11.2020

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¡××××¨××× 2.5/1000 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	MERCK SHARP & DOHME CORP., USA
×©× ××¢× ××¨××©××	MERCK SHARP & DOHME ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 5/2018. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	14/05/2024

השינוי האחרון נעשה בֹ־14 במאי 2024 ב־17:28

סגלורומט 2.5/1000 מ"ג - Segluromet 2.5/1000 mg

ויקיתרופות